Results 141 to 150 of about 33,803 (193)
Some of the next articles are maybe not open access.

Niacin Hepatitis

Southern Medical Journal, 1983
We report a case of severe liver injury occurring on two occasions in a patient ingesting large doses of nicotinic acid. The liver architecture was markedly distorted, with both massive and submassive lobular collapse and marked cholestasis. Complete resolution of biochemical and histologic abnormalities occurred after withdrawal of these drugs.
D J, Patterson   +3 more
openaire   +2 more sources

Niacin and laropiprant

Drugs of Today, 2010
Nicotinic acid (niacin) is one of the oldest drugs used to treat dyslipidemia. In addition to modestly lowering low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a), niacin is currently the most effective available agent for raising high-density lipoprotein cholesterol (HDL-C).
S, Sanyal, J T, Kuvin, R H, Karas
openaire   +2 more sources

Niacin and Carcinogenesis

Nutrition and Cancer, 2003
The dietary status of niacin (vitamin B3) has the potential to influence DNA repair, genomic stability, and the immune system, eventually having an impact on cancer risk, as well as the side effects of chemotherapy in the cancer patient. In addition to its well-known redox functions in energy metabolism, niacin, in the form of NAD, participates in a ...
openaire   +2 more sources

Bioavailability of niacin.

European journal of clinical nutrition, 1997
Chemicals/CAS: Niacin, 59-67-6.
openaire   +2 more sources

Niacin

Nutrition Reviews, 2009
W J, Darby, K W, McNutt, E N, Todhunter
openaire   +2 more sources

Pharmacoepidemiology of Niacin

Annals of Internal Medicine, 1995
P W, Jungnickel, P A, Maloley
openaire   +2 more sources

The use of niacin

Journal of Clinical Lipidology, 2009
W Virgil, Brown   +3 more
openaire   +2 more sources

The Promise of Niacin in Neurology

Neurotherapeutics, 2023
V Wee Yong, Yong V Wee
exaly  

Niacin

Annual Review of Nutrition, 1983
openaire   +2 more sources

Home - About - Disclaimer - Privacy